GAG402 Limited 09558904 false 2025-01-01 2025-12-31 2025-12-31 The principal activity of the company is that of a holding company Digita Accounts Production Advanced 6.30.9574.0 true false false false 09558904 2025-01-01 2025-12-31 09558904 2025-12-31 09558904 core:CurrentFinancialInstruments 2025-12-31 09558904 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 09558904 core:CostValuation 2025-12-31 09558904 core:DisposalsDecreaseInInvestments 2025-12-31 09558904 bus:SmallEntities 2025-01-01 2025-12-31 09558904 bus:Audited 2025-01-01 2025-12-31 09558904 bus:FilletedAccounts 2025-01-01 2025-12-31 09558904 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 09558904 bus:RegisteredOffice 2025-01-01 2025-12-31 09558904 bus:Director3 2025-01-01 2025-12-31 09558904 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 09558904 1 2025-01-01 2025-12-31 09558904 countries:EnglandWales 2025-01-01 2025-12-31 09558904 core:CostValuation 2024-12-31 09558904 2024-01-01 2024-12-31 09558904 2024-12-31 09558904 core:CurrentFinancialInstruments 2024-12-31 09558904 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 iso4217:GBP xbrli:pure

Registration number: 09558904

GAG402 Limited
Filleted Financial Statements
for the Year Ended 31 December 2025

GAG402 Limited

Contents

Balance Sheet | 1
Notes to the Financial Statements | 2 to 4

GAG402 Limited

(Registration number: 09558904)
Balance Sheet as at 31 December 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Investments | 4 | - | 375,000
Current assets |  |  |
Debtors | 5 | 100 | 100
Creditors: Amounts falling due within one year | 6 | - | (375,000)
Net current assets/(liabilities) |  | 100 | (374,900)
Net assets |  | 100 | 100
Capital and reserves |  |  |
Called up share capital |  | 100 | 100
Shareholders' funds |  | 100 | 100

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 30 April 2026 and signed on its behalf by:

......................................... Mr S Taylor Director

GAG402 Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Network House
Western Way
Bury St Edmunds
Suffolk
IP33 3SP

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are presented in sterling, which is the functional currency of the company.

Summary of disclosure exemptions

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland", not to disclose related party transactions with wholly owned subsidiaries within the group..

Name of parent of group

These financial statements are consolidated in the financial statements of Bio Scope 3 Limited.

The financial statements of Bio Scope 3 Limited may be obtained from Companies House.

Going concern

These financial statements have been prepared on a non-going concern basis. The directors have concluded that it is not appropriate to adopt the going concern basis of accounting, as the company is no longer trading and the directors have planned to apply for the company’s dissolution in the near future.

Audit report

The Independent Auditor's Report was unqualified. We draw attention to note 2 to the financial statements which explains that the directors intend to liquidate the company and therefore do not consider it to be appropriate to adopt the going concern basis of accounting in preparing the financial statements. Accordingly, the financial statements have been prepared on a basis other than going concern as described in note 2. Our opinion is not modified in respect of this matter. The name of the Senior Statutory Auditor who signed the audit report on 12 May 2026 was Caroline Webster FCA, who signed for and on behalf of UHY Ross Brooke.

GAG402 Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

Business combinations

Business combinations are accounted for using the purchase method. The consideration for each acquisition is measured at the aggregate of the fair values at acquisition date of assets given, liabilities incurred or assumed, and equity instruments issued by the group in exchange for control of the acquired, plus any costs directly attributable to the business combination. When a business combination agreement provides for an adjustment to the cost of the combination contingent on future events, the group includes the estimated amount of that adjustment in the cost of the combination at the acquisition date if the adjustment is probable and can be measured reliably.

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.
Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 4 (2024 - 4).

4 | Investments

| 2025 £ | 2024 £
Investments in subsidiaries | - | 375,000

Subsidiaries | £
Cost or valuation
At 1 January 2025 | 375,000
Disposals | (375,000)
At 31 December 2025 | -
Provision
Carrying amount
At 31 December 2025 | -
At 31 December 2024 | 375,000

GAG402 Limited

Notes to the Financial Statements for the Year Ended 31 December 2025

5 | Debtors

Current | Note | 2025 £ | 2024 £
Amounts owed by related parties |  | 100 | 100
|  | 100 | 100

6 | Creditors

Creditors: amounts falling due within one year

| Note | 2025 £ | 2024 £
Due within one year |  |  |
Amounts owed to related parties |  | - | 375,000

7 | Parent and ultimate parent undertaking

The company's immediate parent is Bio Scope 3 Limited, incorporated in England and Wales.
The most senior parent entity producing publicly available financial statements is Bio Scope 3 Limited. These financial statements are available upon request from Companies House